Purinergic signaling promotes gliomagenesis through nuclear calcium transients
Shuai Wang, Jenna Richter, Claire Kim…·Dimitris G. Placantonakis
This study identifies purinergic signaling via P2RY1 receptors and nuclear calcium transients as a driver of glioblastoma tumorigenesis, with therapeutic potential through P2RY1 inhibition.